Kinetic analysis of LDL oxidation in IHD and IHD risk subjects in Indian population

Indian Journal of Clinical Biochemistry

Volumn 18, Issue 1, 2003, Pages 35-45

  Gupta, Yashika ^c   Mallika, V ^a   Srivastava, D K ^b  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

^c NONE   (United States)

Author keywords

Cholesterol; FAG; HPLC; Kinetics; LDL; Ox LDL

Indexed keywords

20ALPHA HYDROXYCHOLESTEROL; AMINO ACID; APOLIPOPROTEIN; CHOLEST 4 EN 3 ONE; CHOLESTEROL DERIVATIVE; COPPER; COPPER SULFATE; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; INDIA; ISCHEMIC HEART DISEASE; KINETICS; MALE; OXIDATION; RISK FACTOR;

EID: 0042978569     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867663     Document Type: Article

References (23)

1. Goldstein, J.L. and Brown, M.S. (1977) The low-density lipoprotein pathway and relation to atherosclerosis. Annu. Rev. Biochem. 46, 897-930.
2. Steinberg, D. (1983). Lipoproteins and atherosclerosis: a look back and a look ahead. Arteriosclerosis 3, 283-301.
3. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989). Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenieity. N. Engl. J. Med. 320, 915-924.
4. Newman, H.A.J. and Zilversmit, D.B. (1962). Quantitative aspects of cholesterol flux in rabbit atheromatus lesions. J. Biol. Chem. 237, 2078-2084.
5. Baynes, J.W. and Thorpe, S.R. (2000). Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med. 28, 1708-1716.
6. Pordrez, E.A., Abu-Soud, H.M. and Hazen, S.L. (2000). Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28, 1717-1725.
7. Meagher, E.A. and Fritzgerald, G.A. (2000). Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic. Biol. Med. 28, 1745-1750.
8. Uchida, K. (2000). Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 28, 1685-1696.
9. Ehara, S. Ueda, M., Naruko, T., Haze, K., Matsuo, T., Ogami, M., Ikura, Y., Itabe, H., Komatsu, R., Yoshiyama, M., Takeuchi, K. and Yoshikawa, J. (2002) Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases. J. Diabetes and Its Compl. 16, 60-64.
10. Carr, A. and Frei, B. (2000). The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic. Biol. Med. 28, 18-0-1814.
11. Burnstein, M., Scolnick, H.R. and Morfin, R. (1970). Rapid method for the isolation of lipoproteins from human serum by precipitation with polyamines. J. Lipid Res. 2, 583-595.
12. Chung, B.H., Wilkinson, T., Geer, J.L. and Segrest, J.P. (1986). Preparative and quantitative isolation of plasma lipoproteins: rapid single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21, 284-291.
13. Buege, J.A. and Aust, S.D. (1978). Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310.
14. Steinbrecher, U.P. (1987). Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262, 3603-3608.
15. Liu, K., Cuddy, T.E. and Pierce, G.N. (1992). Oxidative status of lipoproteins in coronary disease patients. Am. Heart J. 123, 285-290.
16. Chiu, H.C., Jeng, J.R. and Shieh, S. (1994). Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Biochim. Biophys. Acta 1225, 200-208.
17. Frostegard, J., Wu, R., Giscombe, R., Holm, G., Lefvert, A.K. and Nilsson, J. (1992). Induction of T-cell activation by oxidized low density lipoprotein. Arterios. Thromb. 12, 461-467.
18. Steinbrecher, U.P., Witztum, J.L., Parthasarathy, S. and Steinberg, D. (1987). Decrease in reactive free amino groups during oxidation or endothelial cell modification of LDL: correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1, 135-143.
19. Lavy, A., Brook, J.G., Dankner, G., Ben-Amotz, A. and Aviram, M. (1991). Ehanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40, 794-799.
20. Cominacini, L., Garbin, U., Pastorino, A.M., Davoli, A., Campagnola, M., DeSantis, A., Pasini, C., Fasccini, G.B., Trevisan, M.T., Bertozzo, L., Posini, F. and Lo Cascio, V. (1993). Predisposition of LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 99, 63-70.
21. Addis, P.B., Emanuel, H.A., Bergman, S.D. and Zavoral, J.H. (1989). Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radic. Biol. Med. 7, 179-182.
22. Javitt, N.B., Kok, E., Burnstein, S., Cohen, B. and Kutscher, J. (1981). 26-hydroxycholesterol, identification and quantitation in human serum. J. Biol. Chem. 256, 12644-12646.
23. Kutryk, J.B., Maddaferd, T.G., Ramjiawan, B. and Pierce, G.N. (1991). Oxidation of membrane cholesterol alters active and passive trans-sarcolemmal calcium movement. Circ. Res. 68, 18-26.